These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. "The Duesberg phenomenon": Duesberg and other voices. Delaney M Science; 1995 Jan; 267(5196):314. PubMed ID: 7824920 [No Abstract] [Full Text] [Related]
5. "The Duesberg phenomenon": what does it mean? Van Rompay K; Marthas ML Science; 1995 Jan; 267(5195):157. PubMed ID: 7809614 [No Abstract] [Full Text] [Related]
6. "The Duesberg phenomenon": Duesberg and other voices. Plotkin SA Science; 1995 Jan; 267(5196):315-6. PubMed ID: 7880305 [No Abstract] [Full Text] [Related]
7. "The Duesberg phenomenon": Duesberg and other voices. Duesberg PH Science; 1995 Jan; 267(5196):313-4; author reply 316. PubMed ID: 7824919 [No Abstract] [Full Text] [Related]
8. Zidovudine and the natural history of AIDS. N Engl J Med; 1991 Oct; 325(18):1311-3. PubMed ID: 1922230 [No Abstract] [Full Text] [Related]
10. [Prolonged survival in patients with progressive multifocal leukoencephalopathy associated with AIDS treated with high doses of zidovudine]. Martín-Suárez I; Aguayo Canela M; Merińo Muñoz D; Pujol de la Llave E Rev Clin Esp; 1994 Feb; 194(2):136-8. PubMed ID: 8008938 [No Abstract] [Full Text] [Related]
11. Zidovudine therapy, CD4+ and CD8+ counts are associated with a longer survival following AIDS onset. Fiala M; Swartz J; Teklehaimanot S; Kermani V; Funnye AS; Sayre JW; Gornbein JA Lymphology; 1997 Sep; 30(3):128-36. PubMed ID: 9313205 [TBL] [Abstract][Full Text] [Related]
12. AIDS--1996. Figueroa JP West Indian Med J; 1996 Dec; 45(4):103-4. PubMed ID: 9033226 [No Abstract] [Full Text] [Related]
13. The efficacy of zidovudine is time limited. Moore RD; Chaisson RE; Hidalgo J JAMA; 1994 Oct; 272(13):1001; author reply 1001-2. PubMed ID: 8089879 [No Abstract] [Full Text] [Related]
14. The efficacy of zidovudine is time limited. Berman DS; Wenglin BD JAMA; 1994 Oct; 272(13):1001; author reply 1001-2. PubMed ID: 8089878 [No Abstract] [Full Text] [Related]
16. Risk factors for Kaposi's sarcoma in patients with advanced human immunodeficiency virus disease treated with zidovudine. Zidovudine Epidemiology Study Group. Gallant JE; Moore RD; Richman DD; Keruly J; Chaisson RE Arch Intern Med; 1994 Mar; 154(5):566-72. PubMed ID: 8122950 [TBL] [Abstract][Full Text] [Related]
17. [Risk of the development of dementia after interruption of zidovudine treatment]. Teira R; Uriarte E; Muñoz J; Uterga JM; Sádaba F; Zubero Z; Santamaría JM Med Clin (Barc); 1998 Sep; 111(9):325-8. PubMed ID: 9810533 [TBL] [Abstract][Full Text] [Related]
20. Antiretroviral treatment of men infected with human immunodeficiency virus type 1 reduces the incidence of heterosexual transmission. Italian Study Group on HIV Heterosexual Transmission. Musicco M; Lazzarin A; Nicolosi A; Gasparini M; Costigliola P; Arici C; Saracco A Arch Intern Med; 1994 Sep; 154(17):1971-6. PubMed ID: 8074601 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]